Effects of N-acetylcysteine on Diabetic Foot Oxygenation
Information source: University of Turin, Italy
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Foot Ulcer, Diabetic
Intervention: N-acetylcysteine (Drug); Placebo (Drug)
Phase: Phase 3
Status: Completed
Sponsored by: University of Turin, Italy Official(s) and/or principal investigator(s): Valentino Martina, Professor, Principal Investigator, Affiliation: University of Turin
Summary
The purpose of this study is to determine whether N-acetylcysteine is effective in the
treatment or prevention of the foot ulcers in diabetic patients.
Clinical Details
Official title: Effects of Prolonged N-acetylcysteine Administration on Foot Ulcer Oxygenation in Diabetic Patients
Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Primary outcome: Tissue oxygenation improvement
Secondary outcome: Improvement of the endothelial functionOxidation status reduction
Eligibility
Minimum age: 45 Years.
Maximum age: 70 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Age between 45 and 70 years.
- Type 1 or 2 diabetes mellitus with foot ulcer (grade 0 stage C according to Texas
University Classification).
- Written informed consent.
Exclusion Criteria:
- N-acetylcysteine assumption in the 6 months previous to the study.
- Hypersensibility to acetylcysteine.
- Neoplasms, severe systemic, hepatic, pulmonary, cardiovascular or renal diseases.
- Psychiatric diseases or drug abuse problems.
Locations and Contacts
Div. Endocrinology, Diabetology and Metabolism - University of Turin, Turin, TO 10126, Italy
Additional Information
International Working Group on the Diabetic Foot
Related publications: Martina V, Masha A, Gigliardi VR, Brocato L, Manzato E, Berchio A, Massarenti P, Settanni F, Della Casa L, Bergamini S, Iannone A. Long-term N-acetylcysteine and L-arginine administration reduces endothelial activation and systolic blood pressure in hypertensive patients with type 2 diabetes. Diabetes Care. 2008 May;31(5):940-4. doi: 10.2337/dc07-2251. Epub 2008 Feb 11. Masha A, Brocato L, Dinatale S, Mascia C, Biasi F, Martina V. N-acetylcysteine is able to reduce the oxidation status and the endothelial activation after a high-glucose content meal in patients with Type 2 diabetes mellitus. J Endocrinol Invest. 2009 Apr;32(4):352-6. Martina V, Bruno GA, Zumpano E, Origlia C, Quaranta L, Pescarmona GP. Administration of glutathione in patients with type 2 diabetes mellitus increases the platelet constitutive nitric oxide synthase activity and reduces PAI-1. J Endocrinol Invest. 2001 Jan;24(1):37-41. Ignarro LJ, Edwards JC, Gruetter DY, Barry BK, Gruetter CA. Possible involvement of S-nitrosothiols in the activation of guanylate cyclase by nitroso compounds. FEBS Lett. 1980 Feb 11;110(2):275-8.
Starting date: August 2009
Last updated: March 7, 2012
|